##semicolon##
оғир бош мия жароҳати, иккиламчи шикастланиш, циклооксигеназа, нейрояллиғланиш, мия шиши, қон-мия тўсиғи бузилиши, простагландинлар, цог ингибиторлари, нейропротекция, патогенетик терапия.##submission.citations##
Al Masri M, Corell A. The glymphatic system for neurosurgeons: a scoping review. Neurosurg Rev. 2024;47:61.
Bergold PJ. Treatment of BMJ with anti-inflammatory drugs. Exp Neurol. 2016;275:367-380.
Buccilli B, Alan A. Neuroprotection strategies in traumatic brain injury: Studying the effectiveness of different clinical approaches. Surg Neurol Int. 2024;15:29.
Candelario-Jalil E, Fiebich BL. Cyclooxygenase inhibition in ischemic brain injury. Curr Pharm Des. 2008;14(14):1401-1418.
Corrigan F, Mander KA. Neurogenic inflammation after BMJ and its potentiation of classical inflammation. J Neuroinflammation. 2016;13:264.
Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1080-1097.
Edlow BL, Chatelle C, et al. Early detection of consciousness in patients with acute severe traumatic brain injury. Brain. 2017;140:2399-2414.
Exadaktylos A, Ziaka M. Brain-lung interactions and mechanical ventilation in patients with isolated brain injury. Crit Care. 2021;25:358.
Feng S, Wu Z, et al. Abnormal levels of expression of microRNAs in peripheral blood of BMJ patients are correlated with severity of injury. Eur J Med Res. 2024;29(3):188.
Feng S, Wu Z, et al. Abnormal levels of expression of microRNAs in peripheral blood of patients with traumatic brain injury are induced by microglial activation and correlated with severity of injury. Eur J Med Res. 2024;29:188.
Freeman WD. How I manage IKB-CPP: A visual, yet individualized approach. Crit Care. 2019; 23(1):287.
Gopez JJ, Yue H, et al. Cyclooxygenase-2 inhibition improves functional outcomes, provides neuroprotection, and reduces inflammation in BMJ. Neurosurgery. 2005;56(3):590-604.
Hickey RW, Adelson PD, et al. Cyclooxygenase-2 Activity Following Traumatic Brain Injury in the Developing Rat. Pediatr Res. 2007;62(3):271-276.
Hiskens MI, Schneiders AG. Selective SOG-2 inhibitors as neuroprotective agents in BMJ. Biomedicines. 2024;12(3):1930.
Jha RM, Kochanek PM, Simard JM. Pathophysiology and treatment of cerebral edema in BMJ. Neuropharmacology. 2019;145(Pt B):230-246.
Jha RM, Kochanek PM, Simard JM. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology. 2019;145 (Pt B):230-246.
Jiang H, Yang X, Wang Y, Zhou C. Vitamin D protects against BMJ via modulating TLR4/MyD 88/NF-κB pathway-mediated neuroinflammation. Biomed Res Int. 2022;33(4):3363036.
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga. Adherence of NSAID Administration in Patients with Mild and Moderate Traumatic Brain Injury. JUXTA. 2021;XII(02):90-93.
Kalra S, Malik R, et al. Pathogenesis and management of BMJ: Role of neuroinflammation and anti-inflammatory drugs. Inflammopharmacology. 2022;30(6):1153-1166.
Kinoshita K. Traumatic brain injury: Pathophysiology for neurocritical care. J Intensive Care. 2016;4:29.
Lindblad C, Rostami E, Helmy A. Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury. Neurotherapeutics. 2023;20(6):1508-1528.
Loane DJ, Faden AI. Neuroprotection in traumatic brain injury: The role of pharmacotherapy. Neurotherapeutics. 2010;7(1):100-114.
Maas AI, Menon DK. Traumatic brain injury: Progress and challenges in prevention, clinical care, and research. Lancet Neurol Commissions. 2022;4:1004-1060.
Mallah K, Couch C, et al. Anti-inflammatory and neuroprotective agents in CNS disease and injury. Front Immunol. 2020;11:1-20.
Rizoli SB, Jaja BNR. Catecholamines as outcome markers in BMJ: The COMA-BMJ study. Crit Care. 2017;21:37.
Robba C, Poole D, McNett M. Mechanical ventilation in patients with acute brain injury: Recommendations of the European Society of Intensive Care Medicine. Intensive Care Med. 2020;46:2397-2410.
Silvestro S, Raffaele I, et al. Innovative Insights into Traumatic Brain Injuries: Biomarkers and New Pharmacological Targets. Int J Mol Sci. 2024;1-43.
Spiera Z, Hannah T, et al. Nonsteroidal anti-inflammatory drug use and concussions in adolescent athletes: incidence, severity, and recovery. Neurosurg Pediatr. 2021;28:476-482.
Stamatovic SM, Dimitrijevic OB, et al. Inflammation and brain edema: New insights into the role of chemokines and their receptors. Brain Edema XIII. 2006;444-450.
Stocchetti N, Maas AIR. Traumatic intracranial hypertension. N Engl J Med. 2014;370(22): 2121-2130.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness: A practical scale. Lancet. 1974;2(72):81-84.
Vella MA, Crandall M. Acute Management of Traumatic Brain Injury. Surg Clin North Am. 2017; 97(5):1015-1030.
Woodling NS, Colas D, et al. Cyclooxygenase inhibition targets neurons to prevent early behavioral decline in Alzheimer's disease model mice. Brain. 2016;139(6):2063-2081.
Zeng Z, Wei L, et al. The Effect of Dexamethasone on Neuroinflammation and Cerebral Edema in Rats With Traumatic Brain Injury Combined With Seawater Drowning. Cureus. 2024;16(3):e55309.
Ziaka M, Exadaktylos A. Brain–lung interactions and mechanical ventilation in patients with isolated brain injury. Crit Care. 2021;25:358.